Floatz logo

PRAVASTATIN

HIV Infections

Ospedale di Circolo - Fondazione MacchiSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
81/ 100

Competitive context

62 Active assets in the HIV Infections cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
Abacavir
Germans Trias i Pujol Hospital
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 50 →

Same molecule, other indications

PRAVASTATIN is also rated in:

lipodystrophyDormant
BBB
Indicative ·
76 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative ·
76 / 100
View asset →
metabolic diseaseDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →